Showing results (771-780 of 8,009) with videos related to

Sort By:
Pageof 801
Current Medicinal Chemistry|January 24, 2025
Exploring the Therapeutic Potential of Plumbagin: Its Current Applications in Cancer and Neuropsychiatric DisordersTingting Jiang, Dongsheng Zhou, Jiahui Wang, et al.
Current Medicinal Chemistry|January 16, 2025
Cordycepin and Its Structural Derivatives Effectively Suppress the High Expression of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase in Breast Carcinomas: A Computational Drug Development ApproachShabana Bibi, Partha Biswas, Md Mohaimenul Islam Tareq, et al.
Current Medicinal Chemistry|January 16, 2025
Experimental Research Progress of mPGES-1 Inhibitor 2,5-Dimethylcelecoxib in Various DiseasesZhanfei Chen, Rong Chen, Laiping Wang, et al.
Current Medicinal Chemistry|January 16, 2025
Mitochondrial DNA Mutations as a Factor in the Heritability of Atherosclerosis and Other DiseasesAlexander N Orekhov, Nikolay A Orekhov, Vasily N Sukhorukov, et al.
Current Medicinal Chemistry|January 16, 2025
Theoretical Modeling of the Interactions of CoFe2O4-BaTiO3 Magnetoelectric Nanoparticles with Cancer and Healthy CellsGençay Sevim, Gizem Değer, Gülay Büyükköroğlu
Current Medicinal Chemistry|January 14, 2025
Current Scenario in Associating Clinical COVID-19 Biomarkers for Developing Surveillance PlatformsThangavel Lakshmipriya, Subash C B Gopinath, Yeng Chen, et al.
Current Medicinal Chemistry|January 8, 2025
An Azomethine Derivative, 1-(4-nitrophenyl)-N-phenylmethanimine (BCS2) Ameliorated 7,12-dimethylbenz(a)anthracene-induced Mammary Carcinoma through Nrf2-Keap1-HO-1 PathwayReetuparna Acharya, Pran Kishore Deb, Shakti Prasad Pattanayak
Current Medicinal Chemistry|January 8, 2025
The Interplay of Diet, Genome, Metabolome, and Gut Microbiome in Cardiovascular Disease: A Narrative ReviewManije Darooghegi Mofrad, Seoeun Ahn, Ock K Chun
Current Medicinal Chemistry|January 8, 2025
Interaction between microRNA and KRAS in GlioblastomaOzal Beylerli, Elmar Musaev, Gervith Reyes Soto, et al.
Current Medicinal Chemistry|January 4, 2025
Pro-renin Receptor (PRR) as a Target to Reduce Non-alcoholic Fatty Liver Disease Post Liver TransplantationRozita Khodashahi, Gordon A Ferns, Mohsen Aliakbarian, et al.
Pageof 801